APOE -: 491 promoter polymorphism is a risk factor for late-onset Alzheimer's disease

被引：33
|
作者：
Casadei, VM
Ferri, C
Veglia, F
Gavazzi, A
Salani, G
Cattaneo, M
Sorbi, S
Annoni, G
Licastro, F
Mariani, C
Franceschi, M
Grimaldi, LME
机构：
[1] Ist Sci San Raffaele, Clin Santa Maria Castellanza, Neuroimmunol Unit, Dept Neurosci, I-20132 Milan, Italy
[2] Ist Sci San Raffaele, Clin Santa Maria Castellanza, Neuroimmunol Unit, Biostat Unit, I-20132 Milan, Italy
[3] Ist Sci San Raffaele, Clin Santa Maria Castellanza, Dept Neurol, I-20132 Milan, Italy
[4] CNR, Ist Tecnol Biomed Avanzate, I-20131 Milan, Italy
[5] Univ Florence, Dept Neurol & Psychiat Sci, I-50121 Florence, Italy
[6] Univ Milan, Dept Geriatr, I-20122 Milan, Italy
[7] Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy
[8] IRCCS Santa Maria Nascente, Neurorehabil Unit, Milan, Italy
[9] IRCCS Oasi Maria Santissima, Troina, Italy
来源：
NEUROLOGY | 1999年 / 53卷 / 08期
关键词：
APOE; AD; polymorphisms;
D O I：
10.1212/WNL.53.8.1888
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1888 / 1889
页数：2
相关论文
共 50 条
  • [11] Apolipoprotein E-491 promoter polymorphism is an independent risk factor for Alzheimer's disease in the Chinese population
    Yang, JD
    Feng, GY
    Zhang, J
    Cheung, J
    St Clair, D
    He, L
    [J]. NEUROSCIENCE LETTERS, 2003, 350 (01) : 25 - 28
  • [12] Tumor necrosis factor α and interleukin 10 promoter region polymorphisms and risk of late-onset Alzheimer disease
    Ramos, Erin M.
    Lin, Ming-Tesh
    Larson, Eric B.
    Maezawa, Izumi
    Tseng, Li-Hui
    Edwards, Karen L.
    Schellenberg, Gerard D.
    Hansen, John A.
    Kukull, Walter A.
    Jin, Lee-Way
    [J]. ARCHIVES OF NEUROLOGY, 2006, 63 (08) : 1165 - 1169
  • [13] Identification of GAB2 as a risk factor for late-onset Alzheimer's disease
    不详
    [J]. FUTURE NEUROLOGY, 2007, 2 (04) : 357 - 357
  • [14] Plasma cholesterol and risk for late-onset Alzheimer's disease
    Cedazo-Minguez, Angel
    Ismail, Muhammad-Al-Mustafa
    Mateos, Laura
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2011, 11 (04) : 495 - 498
  • [15] ApoE −491A/T Promoter Polymorphism is not an Independent Risk Factor, but Associated with the ε4 Allele in Hungarian Alzheimer’s Dementia Population
    Anna Juhász
    András Palotás
    Zoltán Janka
    Ágnes Rimanóczy
    Miklós Palotás
    Nikoletta Bódi
    Krisztina Boda
    Marianna Zana
    Gábor Vincze
    János Kálmán
    [J]. Neurochemical Research, 2005, 30 : 591 - 596
  • [16] ApoE-491A/T promoter polymorphism is not an independent risk factor, but associated with the ε4 allele in Hungarian Alzheimer's dementia population
    Juhász, A
    Palotás, A
    Janka, Z
    Rimanóczy, A
    Palotás, M
    Bódi, N
    Boda, K
    Zana, M
    Vincze, G
    Kálmán, J
    [J]. NEUROCHEMICAL RESEARCH, 2005, 30 (05) : 591 - 596
  • [17] A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's Disease
    Lambert, JC
    Pasquier, F
    Cottel, D
    Frigard, B
    Amouyel, P
    Chartier-Harlin, MC
    [J]. HUMAN MOLECULAR GENETICS, 1998, 7 (03) : 533 - 540
  • [18] Promoter polymorphism (–491A/T) in the APOE gene of Finnish Alzheimer’s disease patients and control individuals
    S. Helisalmi
    Mikko Hiltunen
    Piia Valonen
    Arto Mannermaa
    Anne Maria Koivisto
    Maarit Lehtovirta
    Markku Ryynänen
    Hilkka Soininen
    [J]. Journal of Neurology, 1999, 246 : 821 - 824
  • [19] Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals
    Helisalmi, S
    Hiltunen, M
    Valonen, P
    Mannermaa, A
    Koivisto, AM
    Lehtovirta, M
    Ryynänen, M
    Soininen, H
    [J]. JOURNAL OF NEUROLOGY, 1999, 246 (09) : 821 - 824
  • [20] Is MTHFR polymorphism a risk factor for Alzheimer's disease like APOE?
    Fernandez, LL
    Scheibe, RM
    [J]. ARQUIVOS DE NEURO-PSIQUIATRIA, 2005, 63 (01) : 1 - 6
12345